A. Nanda

发表

Tumor endothelial markers: new targets for cancer therapy

B. St. Croix, Brad St Croix, A. Nanda, 2004, Current opinion in oncology.

Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk.

A. D'Amico, Ming-Hui Chen, L. Braunstein, 2015, Clinical genitourinary cancer.

Mathematical rigor is necessary, but for men with prostate cancer, clinical relevance is the priority.

A. D'Amico, Ming-Hui Chen, A. Nanda, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.

D. Dias-Santagata, T. Lynch, H. Willers, 2008, Clinical lung cancer.

Consensus Statement on Proton Therapy for Prostate Cancer

J. Liao, W. Mendenhall, N. Vapiwala, 2021, International journal of particle therapy.

Hormonal therapy and radiation for prostate cancer: is it safe?

A. D'Amico, A. Nanda, 2010, Expert review of anticancer therapy.

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.

J. Settleman, C. Benes, M. Krause, 2011, Cancer research.

Therapeutics , Targets , and Chemical Biology EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells SustainingDNADouble-Strand Breaks

J. Settleman, C. Benes, M. Krause, 2011 .

TEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI)

K. Kinzler, B. Vogelstein, S. Seaman, 2004, Cancer Research.

Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors.

K. Kinzler, B. Vogelstein, D. Huso, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.

R. Hannan, Y. Lotan, Xian-Jin Xie, 2016, European journal of cancer.

Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease.

A. D'Amico, Ming-Hui Chen, B. Moran, 2014, European urology.

Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, International journal of radiation oncology, biology, physics.

Combined radiation and hormonal therapy or dose escalation for men with unfavourable‐risk prostate cancer: an evidence‐based approach using a synthesis of randomized clinical trials

A. D'Amico, A. Nanda, 2008, BJU international.

Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2013, International journal of radiation oncology, biology, physics.

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.

A. D'Amico, Ming-Hui Chen, B. Moran, 2009, JAMA.

Cell surface tumor endothelial markers are conserved in mice and humans.

K. Kinzler, B. Vogelstein, D. N. Watkins, 2001, Cancer research.

Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.

Yair Lotan, Robert D Timmerman, Alana Christie, 2014, International journal of radiation oncology, biology, physics.

Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, International journal of radiation oncology, biology, physics.

Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.

A. Renshaw, A. D'Amico, Ming-Hui Chen, 2009, International journal of radiation oncology, biology, physics.

Identification of Amino Acids That Modulate Mannose Phosphorylation of Mouse DNase I, a Secretory Glycoprotein*

S. Kornfeld, J. Frenz, A. Nishikawa, 1999, The Journal of Biological Chemistry.

Sign of Leser-Trélat in newly diagnosed advanced gastric adenocarcinoma.

C. Fuchs, H. Mamon, A. Nanda, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advances in Brief Cell Surface Tumor Endothelial Markers Are Conserved in Mice and Humans 1

K. Kinzler, B. Vogelstein, D. N. Watkins, 2001 .

TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).

K. Kinzler, B. Vogelstein, S. Seaman, 2004, Cancer research.

Identification of a Binding Partner for the Endothelial Cell Surface Proteins TEM7 and TEM7R

K. Kinzler, B. Vogelstein, S. Seaman, 2004, Cancer Research.

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.

A. D'Amico, Ming-Hui Chen, B. Moran, 2009, JAMA.